Kistler Tiffany Companies, LLC Abb Vie Inc. Transaction History

Kistler Tiffany Companies, LLC

$615 Million
Q2 2023

A detailed history of Kistler Tiffany Companies, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 12,580 shares of ABBV stock, worth $2.26 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

12,580

Previous 12,314 2.16%

Holding current value

$2.26 Million

Previous $1.96 Million 13.66%

% of portfolio

0.28%

Previous 0.37%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$132.51 - $164.9 $35,247 - $43,863	266 Added 2.16%	12,580 $1.69 Million
Q1 2023 May 03, 2023	BUY	$144.61 - $166.54 $10,122 - $11,657	70 Added 0.57%	12,314 $1.96 Million
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $93,359 - $111,962	-675 Reduced 5.22%	12,244 $1.98 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $402 - $461	3 Added 0.02%	12,919 $1.73 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $19,954 - $25,369	-145 Reduced 1.11%	12,916 $1.98 Million
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $21,512 - $26,691	163 Added 1.26%	13,061 $2.12 Million
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $19,659 - $24,875	183 Added 1.44%	12,898 $1.75 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $48,092 - $54,592	452 Added 3.69%	12,715 $1.37 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $137,299 - $152,959	1,305 Added 11.91%	12,263 $1.38 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $76,827 - $84,577	751 Added 7.36%	10,958 $1.19 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $56,825 - $76,721	706 Added 7.43%	10,207 $1.09 Million
Q3 2020 Nov 03, 2020	SELL	$85.91 - $100.83 $56,614 - $66,446	-659 Reduced 6.49%	9,501 $832,000
Q2 2020 Jul 20, 2020	BUY	$73.37 - $98.18 $129,718 - $173,582	1,768 Added 21.07%	10,160 $997,000
Q4 2019 Jan 14, 2020	SELL	$72.13 - $90.25 $14,209 - $17,779	-197 Reduced 2.29%	8,392 $743,000
Q3 2019 Oct 18, 2019	BUY	$62.98 - $75.72 $23,491 - $28,243	373 Added 4.54%	8,589 $650,000
Q2 2019 Jul 22, 2019	BUY	$65.7 - $83.98 $30,156 - $38,546	459 Added 5.92%	8,216 $597,000
Q1 2019 Apr 16, 2019	BUY	$77.14 - $90.79 $49,369 - $58,105	640 Added 8.99%	7,757 $625,000
Q4 2018 Jan 14, 2019	SELL	$77.85 - $96.01 $13,078 - $16,129	-168 Reduced 2.31%	7,117 $656,000
Q3 2018 Oct 19, 2018	BUY	$88.91 - $98.84 $9,513 - $10,575	107 Added 1.49%	7,285 $689,000
Q2 2018 Jul 17, 2018	SELL	$89.78 - $106.23 $1,616 - $1,912	-18 Reduced 0.25%	7,178 $665,000
Q1 2018 Apr 06, 2018	SELL	$92.01 - $123.21 $11,961 - $16,017	-130 Reduced 1.77%	7,196 $681,000
Q4 2017 Jan 11, 2018	BUY	$89.56 - $98.21 $447 - $491	5 Added 0.07%	7,326 $708,000
Q3 2017 Oct 19, 2017	BUY	$69.85 - $89.22 $511,371 - $653,179	7,321	7,321 $651,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.

Account

Kistler Tiffany Companies, LLC Abb Vie Inc. Transaction History